China-based AAQL Africa unveils Sh4.3bn investment in Kenya

6
China-based AAQL Africa unveils Sh4.3bn investment in Kenya
China-based AAQL Africa unveils Sh4.3bn investment in Kenya

Africa-Press – Kenya. Anti-Aging Quantum Living Dr. (AAQL), a prominent health company originally based in China and listed on the US stock market, has announced a $30 million (Sh3.4 billion) investment in the Kenyan e-commerce market.

The announcement was made during an event at the KICC, Nairobi, on Saturday, attended by key figures including Barry Wan (Founder), Andy Hu (Director), and Anton Tscherne (Director of Capital for listed companies in the USA), business leaders and government officials among numerous sales agents across the country.

The funds will be utilised to expand AAQL Africa’s operations in the Kenyan market, boost its product offerings, grow its team, as they plan to enter new markets, including Uganda, Tanzania, Zambia, South Africa, the Democratic Republic of the Congo, Nigeria, Côte d’Ivoire, Ghana, and Egypt.

Barry Wan, the company founder, expressed their intention to penetrate the African e-commerce market, using Kenya as the gateway to other African markets, due to its potential and robust population.

He said the seed capital that the company has invested is aimed at advancing trade and investment partnerships, that create jobs and drive inclusive and sustainable growth.

He emphasised their commitment to investing in Africa’s transformative growth and untapped market opportunities noting that the growth in Africa’s e-commerce market is driven by increasing affluence, population growth, urbanisation rates, and widespread access to the internet.

“The $30 million investment seed capital aims to revolutionise Kenya’s e-commerce sector and generate employment opportunities for Kenyans, with a focus on creating accessible and flexible shopping experiences for consumers across the continent,” he said.

At the same time, the company unveiled health supplements in the Kenyan market, which Barry said they are approved by relevant authorities.

He said that the company’s health supplements, including Glucosamine, Ploblotic, and NMN among others have undergone rigorous testing and approval by key institutions in Kenya.

The firm has manufacturing companies for the supplements in China which is Kenya’s biggest import source, Japan, and the United States.

“The entry of AAQL into the Kenyan market aligns with the growing health consciousness among Kenyans,”Wan noted.

Anton Tscherne, Director of Capital for listed companies in the USA, said the investment signifies AAQL’s confidence in Kenya’s potential for growth and development in both the business and health sectors.

For More News And Analysis About Kenya Follow Africa-Press

LEAVE A REPLY

Please enter your comment!
Please enter your name here